Hay et al. demonstrated that the levels of angiopoietin-2 (Ang2) and von Willebrand factor (vwF) were increased in patients with severe CRS and that they could be used as predictive biomarkers. This evidence concerns the gene ANGPT2 and congenital rubella syndrome.